glp-1 anti-obesity GLP-1R Agonists for Weight Loss A Guide to Weight-Loss Medications:

Sleep apnea In 2024, the FDA approved Zepbound for the treatment of moderate to severe obstructive sleep apnea in adults with obesity, making it the first medication approved for sleep apnea

They are involved throughout the whole drug lifecycle, from investigation and development of a product to post-marketing evaluation

So the whole story started back in early or mid-90s when I first came out of pharmacy school

Pay close attention to how different foods feel during and after eating, and youll build self-awareness that guides your next steps

[Abstract]2025 Apr:406:31-37

Soon came tirzepatideMounjaro, then Zepbound